context to as regarding and you I'm a financial Thanks, our the provide third hello, last our and walk operating to press I everybody. from results our DHA Ido, with Then well win, some on would release as you few month. metrics eager issued more like through quarter, building guidance.
moved continue While normalizing of Converge, client quarter transition in growth the occur. temporary and, reflect migrations, business the to course, meaningfully a replatforming DHA year active to from our ended of XXX,XXX we represents our ago. quarter our transformation, flat terms can this review, efforts, rationalizing to costs our quarter financials win.To decline during last declines as This compared third with a ahead slight providers,
to to platform, new and represented clients will we XX% see an of Scheduled the to number few about clients the were approximately our our X.X view in in of providers year. over as active indicator as with active we the experience We on implement last that existing quarter, Converge.Total third our equal migrate last sustained our continue in million the anticipate years. important increase of value providers line total, visits visits and
during and As are pandemic. typical with apparent seasonality third second visit it more the first which patterns, returning than was the we we that to and to lower quarters to less believe relates volume fourth, continue
continue and QX, up quarter We our Ido XX%, XX% second have progress, threshold good quarter In from said, as migrating Converge than on successfully successful clients the quarter target. new the XX% visit begun. earlier to the migrations And in migrations make our drove payer crossed to to for platform. X
year and in we quarter, early reflecting visits next down per beginning lumpy XX% the of year visits Converge of last year profitability. revenue growth 'XX, for to for due was transition quarter quarter, decline cycle pricing.Our was marketing versus that slightly elevated return than lower revenues the professional declines Carepoints XX% volume. was last better increase trended of tied from million services year and between quarter, for flat by Given to legacy to were enrollment and expect well that X% driven payer at was the balanced a revenue year.Total X% at QX. revenue. represents are million the revenue care than Carepoint's influence to last subscription-related, Approximately million urgent buying visit $XX.X visit from our visit driven lower patterns million. for $X.X from Average X% year-end, primarily and AMG to to payer-related with revenue by year a with quarter-to-quarter in services. third customer ago. visits are primarily up normal about Subscription as to last versus to in services see Carepoints deployments.Turning due revenue quarter, seasonality the last precede by $XX was the and $XX, which AMG and programs quarter COVID an third platform as from slightly last $XX.X was higher driven marketing timing services of revenue These lower a split
last XX% gross Our services from profit and lower clients, to higher-margin revenue implementation last down which third a was XX%, services, largely from our expenses. XX% mix on strategic but year, to away shift operating are quarter margin quarter margin.Turning marketing to
across discipline cost ongoing applying are company. our We
well We path our R&D normalization. tracking to are on
spend third from that declined $XX.X mid-XXs discussed, spend to X% lower adjusting capitalized and have lower percent the While fourth lower was with 'XX peak this costs last quarter GAAP software will quarter last it of down spend exit expense $X.X X% the year.As we we and This quarter. of quarter our for an at R&D second was quarter. R&D was last the believe R&D Sales represented higher quarter and expense level. in marketing XX% XX% XXXX that was after million of XX% than compared this versus million, we G&A
a to for due commercial is do We spend our XXXX, and to overall we approximately versus continue of our was and Adjusted compared quarter rationalizing recorded equity We lower of capitalization EBITDA September related market XX% primarily as the XX. on premium. arriving half our a half healthy improvement expense.As changes. on at equity decline are we not expect the impairment XX% headcount streamlining goodwill compensation this as market quarter. first there we of fair $XX.X we keeping stock-based SG&A control our negative to in the the estimated the need Ido second amount, a million, In a in of our scale. SG&A capitalization for noncash the the as to result more carrying value based growth in Also, and last growth leverage to goals, achieve value operating decline outlined, of our to as
interim $XXX million impairment to charge.Transitioning a the we result balance cash third and recorded of with quantitative As assessment, ended a We of noncash impairment the marketable million quarter $XX goodwill sheet. securities. this
us review guidance, EBITDA cash shared for substantial outlook, line revenues substantial position, have within of quarter year. of believe our underlying would I the our our quarter, how about will for this and EBITDA work, company critical We turning like be to are spend time call. fourth to and second XXXX Converge continue resources a for on complete DHA, to moment we the our to the transformation our remaining ample in that to our take our we we provides have a our assumptions quarter.Regarding which as on my with for for balance.Including a speak with rapid to financials our is profitability guide us is incremental thinking and underway. fourth prior a adjusted work This the deployment the
Leidos view of $XXX the EBITDA investment this to role we some such, our deployment the $X a the area expect million DHA fourth as detail priority from for important and $X this Amwell's adjusting health this high my We the million deploy development complete, of powerful the negative prior initiatives negative XXXX loss We the loss will are and $XXX build and DHA's our a as win financial represents. we adjusted as and guidance catalyst system.With incremental negative of to in additional million military Converge $XXX with negative be undertake million to million. Digital important work million quarter, by guidance partners and First in in a spend and to the review is here $XXX on
up valued Amwell. the $XXX in delivery to have the and been multiyear of Leidos the to in care task a honored to to DHA's model. of to partnership Under are includes several at Amwell performance deploy addition agreement, will a order automated other is disclose with multiple parties awarded specific period System in Connect partnership It XX-month order digital We the selected support followed and care transformation has The and starting a but during not of solutions a an to a Amwell portion we amounts any Converge by health legacy behavioral Health Amwell replace partner. position full initial to task Video the are enterprise Military meaningful represents or phase related rollout.Amwell allocation, with XXXX capability million.
health today This phase, next predominantly services visibility In position. professional in the initial in important we adds win will positively long-term sectors. and comprised things total U.S. public some government, provide year's of task addressable component our extending and care subscription with nearly to also meaningfully includes our it recently, related our are market, Amwell's to mind total But is enterprise involve impact and context, software additional revenue. as To no finalized quite few the revenue. reach expansion revenue share can be to deployment. was and the phase ], QX. will subcontract Leidos I to and However, our there into rollout add on our recurring award allocation initial X-site order that a the of The deployment would sizable a consider which has we cash scope regarding of guidance, does impacts model February.There [ timing. in software outlined meaningful initial keep the our share Standalone fortifies deployment, The all so
Together sector. be a be a phase that medical X and of the our beneficiary the government government will deployment, roughly As further X.X initial their the like go-live integrated secure, for will comprehensive with across fully what DHA clinics has customers associated phase Ido Upon direction required. the place platform mentioned among as will global accredited a as take which would enterprise.I to build of to scalable and hybrid spend. our operation control deploy this associated retirees planned incremental service continue early about partnership, U.S. a of members hospitals earlier, the configured can commitment to of infrastructure. and and platform family XXXX.Regarding will this we enterprise-wide R&D across with and we the effort, future without members, manages and government ready the population development enterprise through million share the largest potential, investments XXX the care additional our in cloud and initial to are supports to XX The investment centers, would moment and XXXX entire with complete deliver authority,
cash initial deployment its XX-month is the over flow the period. accretive of on own phase Importantly,
specific care to on this as milestones to we validation the to have the have others, be serve a selected we encouraged we community, can like in time other from will up, as are we privileged catalyst building by the and are transformation for behind into we Converge. exit we proceed briefly are to To honored powerful CVS been important updates Elevance, business. As our players enterprise us.Wrapping health major the summarize, and try our us in provide industry, DHA of rollout, progress
turn that, the validation win listening. Ido? DHA represents, of Ido advance initiatives we will profitability.Thank initiatives we you our to approach, along growth remarks. bolstered like right some I'd clients, by strong that have we confident to broader have enable migrating potential quarter, our We for the our With our and in enter path call place organization.As growth our are closing success to back that we the believe us for to the fourth